Early Intervention Versus Conservative Management for Asymptomatic Severe Aortic Stenosis: An Updated Meta-Analysis of Randomized Controlled Trials
- PMID: 40172211
- DOI: 10.1097/CRD.0000000000000910
Early Intervention Versus Conservative Management for Asymptomatic Severe Aortic Stenosis: An Updated Meta-Analysis of Randomized Controlled Trials
Abstract
The timely management of asymptomatic severe aortic stenosis (AS) presents an important clinical dilemma. This meta-analysis aims to investigate whether early intervention can lead to improved clinical outcomes compared with conservative management in asymptomatic severe AS. We conducted a literature search of major databases to identify randomized controlled trials that compared an early intervention (either early surgical aortic valve replacement or early transcatheter aortic valve replacement) with conservative management in patients with asymptomatic severe AS. Data for clinical outcomes were extracted, and risk ratios (RRs) were calculated for all end points with corresponding 95% confidence intervals (CIs). The meta-analysis included 4 randomized controlled trials with 1427 patients. Compared with conservative management, early intervention was associated with no significant difference in all-cause [RR, 0.52 (95% CI, 0.23-1.19)] or cardiovascular death [RR, 0.41 (95% CI, 0.10-1.64)]. A statistically significant reduction was observed in the risk of stroke [RR, 0.60 (95% CI, 0.38-0.94)] and unplanned hospitalizations [RR, 0.49 (95% CI, 0.40-0.60)] with an early intervention. The risk of myocardial infarction remained comparable [RR, 0.67 (95% CI, 0.13-3.54)]. Early intervention can be a suitable treatment option for patients with asymptomatic severe AS who prefer proactive management of their condition.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Disclosure: The authors have no conflicts of interest to report.
References
-
- Coffey S, Cox B, Williams MJA. Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades. Am Heart J. 2014;167:562–567.e2.
-
- Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e35–e71.
-
- Vahanian A, Beyersdorf F, Praz F, et al.; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561–632.
-
- Ng ACT, Prihadi EA, Antoni ML, et al. Left ventricular global longitudinal strain is predictive of all-cause mortality independent of aortic stenosis severity and ejection fraction. Eur Heart J Cardiovasc Imaging. 2018;19:859–867.
-
- Bing R, Everett RJ, Tuck C, et al. Rationale and design of the randomized, controlled early valve replacement guided by biomarkers of left ventricular decompensation in asymptomatic patients with severe aortic stenosis (EVOLVED) trial. Am Heart J. 2019;212:91–100.
LinkOut - more resources
Full Text Sources
Research Materials
